Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115527) titled 'The Efficacy and Safety of Remimazolam for Sedation During Arteriovenous Fistula Balloon Dilatation in Patients with Uraemia: A Randomised Controlled Trial' on Dec. 28, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Condition:
uremia
Intervention:
Remimazolam Group:Remimazolam-Assisted Sedation
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Remimazolam Group:40;Control group:40;
Countries of Recruitment:
China
To know more, visit https://www.chic...